Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02348216
Title A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Indications

diffuse large B-cell lymphoma

follicular lymphoma

non-Hodgkin lymphoma

Therapies

axicabtagene ciloleucel

Age Groups: adult | senior
Covered Countries USA | FRA | DEU | CAN

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
City of Hope Duarte California 91010-3012 United States Details
University of California San Diego (UCSD) La Jolla California 92093-0820 United States Details
Stanford University Palo Alto California 94305 United States Details
University of California Los Angeles (UCLA) Santa Monica California 90404 United States Details
Sarah Cannon - Denver Denver Colorado 80218 United States Details
University of Miami Miami Florida 33136 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Loyola University Medical Center Maywood Illinois 60153 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Center Detroit Michigan 48201 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
University of Nebraska Omaha Nebraska 68198-7680 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
University of Rochester Rochester New York 14642 United States Details
Cleveland Clinic - Taussig Cancer Institute Cleveland Ohio 44195 United States Details
Sarah Cannon - Tennesee Nashville Tennessee 37203 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030-4000 United States Details
Sarah Cannon-Methodist Healthcare System - San Antonio San Antonio Texas 78229 United States Details
Vancouver General Hospital Vancouver British Columbia V5Z 1M9 Canada Details
Princess Margaret Toronto Ontario M5G 2M9 Canada Details
Hopital Saint Louis Paris 75475 France Details
Hopital Haut-Leveque Pessac 44035 France Details
CHU de Rennes Rennes 35033 France Details
Universitätsklinik Dresden Dresden 01307 Germany Details
University Hospital of Essen Essen 45147 Germany Details
Universitaetsklinikum Wuerzburg Würzburg 97080 Germany Details
Tel Aviv Souraski Medical Center Tel Aviv 64239 Israel Details
Academisch Medisch Centrum Amsterdam Netherlands Details
University Medical Center Groningen Groningen 9700 RB Netherlands Details
Erasmus MC Rotterdam 3015 CE Netherlands Details
University Medical Center Utrecht Utrecht 3584 CX Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field